Newer medications, such as Mounjaro and Wegovy, exhibit both more total weight lost and faster weight regain than older ...

The drug, liraglutide, is sold under the brand names Victoza and Saxenda. Patents for Victoza and Saxenda have now expired. So other drug companies are working to develop "generic" versions.

Novo Nordisk has settled a US patent case with Teva, which prevents the Israel-based generics firm marketing a cheaper version of its key type 2 diabetes drug Victoza until 2023.

Victoza is Novo Nordisk’s once-daily injectable GLP-1 agonist and made around $3.6 billion in sales last year, making it the top-selling drug in the category.

2024 US FDA approves Hikma's generic version of Novo's diabetes drug Victoza The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's ...